“I don’t think it’s good news to have something that spreads fast,” Pfizer CEO Albert Bourla told The Wall Street Journal.

“Spreads fast means it will be in billions of people and another mutation may come. You don’t want that,” he said.

Bourla cautioned that it is difficult to draw definitive conclusions from the wave of infection in South Africa right now.